Home > Insider Trading > Filing (0001181431-10-058228)

Filing Details

Accession Number:: 0001181431-10-058228
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-30 19:31:32
Reporting Period:: 2010-11-29

Filing Date:: 2010-11-30
Accepted Time:: 2010-11-30 19:31:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1375151	Zogenix Inc.	ZGNX	Pharmaceutical Preparations (2834)	205300780

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1505836	Ken Haas	C/O Abingworth Bioventures 3000 Sand Hill Rd., B4-135 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-29	901,363	$0.00	901,363	No	4	C	Indirect	By Abingworth Bioventures IV LP
Common Stock	Acquisiton	2010-11-29	535,643	$0.00	1,437,006	No	4	C	Indirect	By Abingworth Bioventures IV LP
Common Stock	Acquisiton	2010-11-29	382,613	$0.00	1,819,619	No	4	C	Indirect	By Abingworth Bioventures IV LP
Common Stock	Acquisiton	2010-11-29	495,750	$4.00	2,315,369	No	4	P	Indirect	By Abingworth Bioventures IV LP
Common Stock	Acquisiton	2010-11-29	7,727	$0.00	7,727	No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
Common Stock	Acquisiton	2010-11-29	4,592	$0.00	12,319	No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
Common Stock	Acquisiton	2010-11-29	3,280	$0.00	15,599	No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
Common Stock	Acquisiton	2010-11-29	4,250	$4.00	19,849	No	4	P	Indirect	By Abingworth Bioventures IV Executives L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Abingworth Bioventures IV LP
No	4	C	Indirect	By Abingworth Bioventures IV LP
No	4	C	Indirect	By Abingworth Bioventures IV LP
No	4	P	Indirect	By Abingworth Bioventures IV LP
No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
No	4	C	Indirect	By Abingworth Bioventures IV Executives L.P.
No	4	P	Indirect	By Abingworth Bioventures IV Executives L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2010-11-29	9,013,631	$0.00	901,363	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-11-29	5,356,437	$0.00	535,643	$0.00
Common Stock	8% Convertible Promissory Note	Disposition	2010-11-29	382,613	$0.00	382,613	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2010-11-29	77,278	$0.00	7,727	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-11-29	45,930	$0.00	4,592	$0.00
Common Stock	8% Convertible Promissory Note	Disposition	2010-11-29	3,280	$0.00	3,280	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each of the Series A-2 Convertible Preferred Stock and the Series B Convertible Preferred Stock automatically converted to Common Stock at the closing of the Issuer's initial public offering on November 29, 2010 at a conversion ratio one share of Common Stock for every ten shares of Series A-2 Convertible Preferred Stock and one share of Common Stock for every ten shares of Series B Convertible Preferred Stock, as applicable, rounded down to the next whole number, for no additional consideration.
These securities are owned of record by Abingworth Bioventures IV LP ("AB IV").
These securities are owned of record by Abingworth Bioventures IV Executives L.P. ("AB IV Executives")
Abingworth Management Ltd. ("AM Ltd.") serves as investment manager of each of AB IV and AB IV Executives and may be deemed to share voting and dispositive power with respect to the securities owned by AB IV and AB IV Executives. The Reporting Person is a venture partner of Abingworth Management, Inc., and in such capacity may be deemed to beneficially own the securities owned of record by AB IV and AB IV Executives, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The principle of the Note and accrued interest thereon was automatically converted upon the closing of the Issuer's initial public offering on November 29, 2010 into shares of Common Stock at a conversion price equal to $4.00 per share, the per share price of the Common Stock sold in the Issuer's initial public offering.
The filing of this statement shall not be deemed an admission that, for the purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of equity securities covered by this statement